Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. | Pathogens | 2024 | 38251375 | PubTator, text mining | PubMed |
| Theoretical Studies on the Quantitative Structure-Toxicity Relationship of Polychlorinated Biphenyl Congeners Reveal High Affinity Binding to Multiple Human Nuclear Receptors. | Toxics | 2024 | 38251005 | PubTator, text mining | PubMed |
| Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease. | Theranostics | 2024 | 38250049 | PubTator, text mining | PubMed |
| Trichobezoar Found Accidently while Diagnosing Resistance to Thyroid Hormone. | Case Rep Gastroenterol | 2024 | 38249995 | PubTator, text mining | PubMed |
| Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature. | Dermatopathology (Basel) | 2024 | 38247727 | PubTator, text mining | PubMed |
| Retinoic acid signaling regulates spatiotemporal specification of human green and red cones. | PLoS Biol | 2024 | 38206904 | PubTator, text mining | PubMed |
| Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors. | Int J Mol Sci | 2024 | 38203841 | PubTator, text mining | PubMed |
| Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis. | Metabol Open | 2024 | 38187470 | PubTator, text mining | PubMed |
| Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. | Commun Biol | 2024 | 38172218 | PubTator, text mining | PubMed |
| Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. | Stem Cell Res Ther | 2024 | 38167208 | PubTator, text mining | PubMed |
| A review of sources, pathways, and toxic effects of human exposure to benzophenone ultraviolet light filters. | Eco Environ Health | 2024 | 38162868 | PubTator, text mining | PubMed |
| Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality. | JHEP Rep | 2024 | 38125301 | PubTator, text mining | PubMed |
| Generation of THRB-GS(E125G_G126S) and THRB-KO human iPSC lines to study noncanonical thyroid hormone signalling. | Stem Cell Res | 2024 | 38100912 | PubTator, text mining | PubMed |
| The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease. | Hepatol Commun | 2024 | 38099854 | PubTator, text mining | PubMed |
| Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate? | Food Chem Toxicol | 2024 | 38081530 | PubTator, text mining | PubMed |
| Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components. | Oncol Lett | 2024 | 38058466 | PubTator, text mining | PubMed |
| Rational design of FXR agonists: a computational approach for NASH therapy. | Mol Divers | 2024 | 38055145 | PubTator, text mining | PubMed |
| Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). | Int J Oncol | 2024 | 38038050 | PubTator, text mining | PubMed |
| GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner. | Cell Mol Gastroenterol Hepatol | 2024 | 37844795 | PubTator, text mining | PubMed |
| Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease. | Clin Mol Hepatol | 2024 | 37828839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=17